Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 17 Source: Company
- €541.4 million turnover
-
-€146.6 million
profit - 2,000 employees
-
31st Dec 16 Source: CRO
- €438 million turnover
-
€147.3 million
profit - 380 employees
- 5 more years available »
Ranking
By Turnover
(€541.4 million)- 146th in Top Companies
- 20th in Health
- 17th in Pharma
By Employees
(2,000)- 122nd in Top Companies
- 19th in Health
- 10th in Pharma
-
- 2,000
- €541.4 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- 9:07am Ad giant WPP pulls dividend, buyback and outlook
- 8:26am Penneys puts plan for new store in Dundrum Town Centre on hold
- 7:59am G20 trade chiefs pledge to try to keep supply chains open
- 7:48am UK economy stagnated in fourth quarter, amid turmoil over Brexit
- 7:34am Asian stocks mixed as US futures swing to a loss